- Kenvue Inc. (KVUE, Financial) is set to release its first quarter 2025 financial results on May 8, 2025.
- The earnings announcement will be followed by a conference call and webcast at 8:00 a.m. Eastern Time.
- Kenvue is recognized as the world's largest pure-play consumer health company by revenue.
Kenvue Inc. (KVUE) has announced that it will publish its first quarter 2025 financial results on May 8, 2025, before the market opens. To discuss these results in detail, the company has scheduled a conference call and webcast for 8:00 a.m. Eastern Time on the same day. U.S. participants can join the call by dialing 877-407-8835, while international callers should use +1 201-689-8779. Additionally, a live webcast will be accessible through the company's investor relations website at investors.kenvue.com, with a replay available shortly after the event.
Headquartered in Summit, New Jersey, Kenvue Inc. stands as the largest pure-play consumer health company globally by revenue. The company boasts a rich heritage of over a century, with a portfolio of well-known brands such as Aveeno®, BAND-AID®, Johnson’s®, Listerine®, Neutrogena®, and Tylenol®. Kenvue is dedicated to harnessing the power of everyday care, ensuring its products are backed by scientific research and recommended by healthcare professionals worldwide.
In the market, Kenvue (KVUE, Financial) holds a market cap of $43.96 billion, with a float of 1.92 billion. Insiders own 0.04% of the company's shares, while institutional ownership stands at an impressive 102.41%. The company operates within the household and personal products industry, specifically under the perfume, cosmetics, and other toilet preparations sector.
